Endophytes: a uniquely tailored source of potential antibiotic adjuvants.

Ashaimaa Y Moussa
Author Information
  1. Ashaimaa Y Moussa: Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, African Union Organization Street, Abbassia, Cairo, 11566, Egypt. ashaimaa_yehia@pharma.asu.edu.eg.

Abstract

Multidrug microbial resistance is risking an annual loss of more than 10 million people' lives by 2050. Solutions include the rational use of antibiotics and the use of drugs that reduce resistance or completely obliterate them. Here endophytes come to play due to their high-yield production and inherent nature to produce antimicrobial molecules. Around 40%, 45% and 17% of antibacterial agents were obtained from fungi, actinomycetes, and bacteria, respectively, whose secondary metabolites revealed effectiveness against resistant microbes such as MRSA, MRSE, and Shigella flexneri. Endophyte's role was not confined to bactericidal effect but extended to other mechanisms against MDR microbes, among which was the adjuvant role or the "magic bullets". Scarce focus was given to antibiotic adjuvants, and many laboratories today just screen for the antimicrobial activity without considering combinations with traditional antibiotics, which means real loss of promising resistance combating molecules. While some examples of synthetic adjuvants were introduced in the last decade, the number is still far from covering the disused antibiotics and restoring them back to clinical use. The data compiled in this article demonstrated the significance of quorum sensing as a foreseen mechanism for adjuvants from endophytes secondary metabolites, which call for urgent in-depth studies of their molecular mechanisms. This review, comprehensively and for the first time, sheds light on the significance of endophytes secondary metabolites in solving AMR problem as AB adjuvants.

Keywords

References

  1. ACS Chem Biol. 2013 Jan 18;8(1):226-33 [PMID: 23062620]
  2. PLoS One. 2010 Jul 20;5(7):e11665 [PMID: 20652027]
  3. CPT Pharmacometrics Syst Pharmacol. 2019 Oct;8(10):748-758 [PMID: 31508899]
  4. Antibiotics (Basel). 2021 Aug 17;10(8): [PMID: 34439045]
  5. Nat Rev Microbiol. 2022 May;20(5):257-269 [PMID: 34737424]
  6. Adv Drug Deliv Rev. 2005 Jul 29;57(10):1486-513 [PMID: 15939505]
  7. Saudi Pharm J. 2023 Sep;31(9):101744 [PMID: 37649676]
  8. ChemMedChem. 2008 Feb;3(2):316-22 [PMID: 18038381]
  9. J Org Chem. 2017 Mar 17;82(6):3125-3131 [PMID: 28219242]
  10. J Appl Microbiol. 2002;92 Suppl:46S-54S [PMID: 12000612]
  11. Arch Pharm Res. 2017 Jan;40(1):25-31 [PMID: 27709333]
  12. Nat Rev Microbiol. 2023 May;21(5):280-295 [PMID: 36411397]
  13. J Biol Chem. 2021 Aug;297(2):100918 [PMID: 34181945]
  14. Trends Microbiol. 2014 Aug;22(8):438-45 [PMID: 24842194]
  15. Lancet Microbe. 2023 Jul;4(7):e482-e483 [PMID: 37119824]
  16. Antimicrob Agents Chemother. 2020 Mar 24;64(4): [PMID: 31932375]
  17. ACS Omega. 2023 Mar 14;8(12):10757-10783 [PMID: 37008128]
  18. Lett Appl Microbiol. 2013 Mar;56(3):197-207 [PMID: 23210926]
  19. Int J Mol Sci. 2022 Jul 07;23(14): [PMID: 35886892]
  20. Phytomedicine. 2017 Dec 15;37:14-26 [PMID: 29174600]
  21. Lancet Infect Dis. 2013 Dec;13(12):1057-98 [PMID: 24252483]
  22. Antimicrob Resist Infect Control. 2019 Jul 16;8:118 [PMID: 31346459]
  23. Front Microbiol. 2015 Jul 03;6:669 [PMID: 26191055]
  24. Fitoterapia. 2019 Nov;139:104390 [PMID: 31655088]
  25. Lancet. 2022 Feb 12;399(10325):629-655 [PMID: 35065702]
  26. BMC Complement Med Ther. 2021 Mar 20;21(1):98 [PMID: 33743702]
  27. Appl Microbiol Biotechnol. 2021 Jan;105(1):341-352 [PMID: 33215259]
  28. Microbiol Res. 2016 Oct;191:19-31 [PMID: 27524650]
  29. Biomolecules. 2018 Oct 30;8(4): [PMID: 30380779]
  30. Int J Antimicrob Agents. 2015 Sep;46(3):278-89 [PMID: 26143590]
  31. Chem Biodivers. 2020 Oct;17(10):e2000496 [PMID: 32840051]
  32. World J Microbiol Biotechnol. 2022 Jul 29;38(10):170 [PMID: 35904625]
  33. Can J Microbiol. 2015 Feb;61(2):93-103 [PMID: 25629960]
  34. Chem Biol. 2001 Aug;8(8):791-800 [PMID: 11514228]
  35. J Clin Med. 2020 Jun 03;9(6): [PMID: 32503243]
  36. Biofouling. 2021 Feb;37(2):145-160 [PMID: 33682541]
  37. Heliyon. 2021 Mar 08;7(3):e06362 [PMID: 33869822]
  38. Mycol Res. 2006 Jul;110(Pt 7):811-20 [PMID: 16876700]
  39. Front Antibiot. 2023;2: [PMID: 38983593]
  40. J Glob Antimicrob Resist. 2022 Mar;28:216-222 [PMID: 35017068]
  41. Phytomedicine. 2017 Dec 1;36:254-261 [PMID: 29157822]
  42. Curr Opin Microbiol. 2019 Oct;51:72-80 [PMID: 31733401]
  43. Antimicrob Agents Chemother. 2013 Jan;57(1):637-9 [PMID: 23114759]
  44. J Med Chem. 2019 Oct 10;62(19):8665-8681 [PMID: 31063379]
  45. Biofouling. 2011 Sep;27(8):893-905 [PMID: 21882898]
  46. BMC Biotechnol. 2017 Jul 4;17(1):59 [PMID: 28676112]
  47. J Med Chem. 2014 May 22;57(10):4263-72 [PMID: 24801877]
  48. Front Bioeng Biotechnol. 2020 May 15;8:467 [PMID: 32500068]
  49. Biotechnol Lett. 2017 Jun;39(6):805-817 [PMID: 28275884]
  50. Sci Rep. 2017 Aug 23;7(1):9207 [PMID: 28835636]
  51. J Antibiot (Tokyo). 2013 Aug;66(8):491-3 [PMID: 23677029]
  52. Toxins (Basel). 2020 Jul 08;12(7): [PMID: 32650496]
  53. Arch Pharm Res. 2023 Apr;46(4):273-298 [PMID: 37032397]
  54. Trends Microbiol. 2016 Nov;24(11):862-871 [PMID: 27430191]
  55. Microorganisms. 2017 Dec 12;5(4): [PMID: 29231891]
  56. Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33 [PMID: 20805405]
  57. J Nat Prod. 2022 Apr 22;85(4):846-856 [PMID: 35175766]
  58. J Med Chem. 2019 Apr 11;62(7):3184-3205 [PMID: 30404451]
  59. AIMS Microbiol. 2018 Jun 26;4(3):482-501 [PMID: 31294229]
  60. Sci Rep. 2020 May 18;10(1):8134 [PMID: 32424122]
  61. Biofouling. 2014 Oct;30(9):1111-22 [PMID: 25377484]
  62. ACS Infect Dis. 2019 Jan 11;5(1):9-34 [PMID: 30421910]
  63. J Med Chem. 2012 Apr 12;55(7):3568-72 [PMID: 22432682]
  64. Phytochemistry. 2017 Sep;141:86-97 [PMID: 28586721]
  65. J Biol Chem. 1991 Jul 15;266(20):13329-35 [PMID: 2071605]
  66. Food Res Int. 2022 Dec;162(Pt A):111982 [PMID: 36461225]
  67. Front Pharmacol. 2022 Apr 12;13:896971 [PMID: 35496290]
  68. Antimicrob Agents Chemother. 2021 Feb 17;65(3): [PMID: 33318000]
  69. Pharmaceuticals (Basel). 2022 Mar 21;15(3): [PMID: 35337181]
  70. Nat Prod Rep. 2020 Nov 1;37(11):1454-1477 [PMID: 32608431]
  71. Bioorg Med Chem. 2017 Oct 1;25(19):5133-5141 [PMID: 28784300]
  72. Future Microbiol. 2014;9(10):1165-77 [PMID: 25405886]
  73. Phytochemistry. 2019 Dec;168:112116 [PMID: 31513947]
  74. Crit Rev Microbiol. 2023 Feb;49(1):117-149 [PMID: 35313120]
  75. Nature. 2014 Jun 26;510(7506):503-6 [PMID: 24965651]
  76. Microorganisms. 2021 Aug 25;9(9): [PMID: 34576706]
  77. Steroids. 2017 Dec;128:68-71 [PMID: 29104098]
  78. Front Microbiol. 2020 Jul 27;11:1668 [PMID: 32849344]
  79. Microb Ecol. 2016 Nov;72(4):802-812 [PMID: 27357141]
  80. Molecules. 2023 Feb 10;28(4): [PMID: 36838706]
  81. J Antibiot (Tokyo). 2023 Aug;76(8):431-473 [PMID: 37291465]
  82. Int J Biol Macromol. 2018 Feb;107(Pt A):52-58 [PMID: 28860065]
  83. J Nat Prod. 1997 Nov;60(11):1207-9 [PMID: 9392888]
  84. Clin Microbiol Infect. 2020 Jul;26(7):871-879 [PMID: 31811919]
  85. J Antibiot (Tokyo). 2014 Jan;67(1):43-51 [PMID: 24169797]
  86. Biomolecules. 2020 May 25;10(5): [PMID: 32466324]

MeSH Term

Humans
Anti-Bacterial Agents
Endophytes
Anti-Infective Agents
Adjuvants, Immunologic
Bacteria

Chemicals

Anti-Bacterial Agents
Anti-Infective Agents
Adjuvants, Immunologic

Word Cloud

Created with Highcharts 10.0.0adjuvantsresistanceuseantibioticsendophytessecondarymetaboliteslossantimicrobialmoleculesmicrobesrolemechanismsantibioticsignificanceMultidrugmicrobialriskingannual10millionpeople'lives2050Solutionsincluderationaldrugsreducecompletelyobliteratecomeplayduehigh-yieldproductioninherentnatureproduceAround40%45%17%antibacterialagentsobtainedfungiactinomycetesbacteriarespectivelywhoserevealedeffectivenessresistantMRSAMRSEShigellaflexneriEndophyte'sconfinedbactericidaleffectextendedMDRamongadjuvant"magicbullets"Scarcefocusgivenmanylaboratoriestodayjustscreenactivitywithoutconsideringcombinationstraditionalmeansrealpromisingcombatingexamplessyntheticintroducedlastdecadenumberstillfarcoveringdisusedrestoringbackclinicaldatacompiledarticledemonstratedquorumsensingforeseenmechanismcallurgentin-depthstudiesmolecularreviewcomprehensivelyfirsttimeshedslightsolvingAMRproblemABEndophytes:uniquelytailoredsourcepotentialAntibioticEndophytesMicrobial

Similar Articles

Cited By